Christopher Nishan Garabedian 4
4 · AVI BIOPHARMA INC · Filed Sep 2, 2011
Insider Transaction Report
Form 4
Christopher Nishan Garabedian
Director
Transactions
- Award
Stock Option (right to buy)
2011-08-31+200,000→ 200,000 totalExercise: $1.24Exp: 2021-08-31→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]This option is exercisable at the rate of 25% of the shares on August 31, 2012 and 1/48th of the total granted shares on each monthly anniversary thereafter, such that the option will be fully exercisable on August 31, 2015.